The new science behind the health benefits of caffeine

Study finds that consuming more caffeine may improve heart health.

Study: Caffeine improves systemic lupus erythematosus endothelial dysfunction by promoting endothelial progenitor cells survival. Image Credit: Mixa74/Shutterstock.com
Study: Caffeine improves systemic lupus erythematosus endothelial dysfunction by promoting endothelial progenitor cells survival. Image Credit: Mixa74/Shutterstock.com

Systemic lupus erythematosus (SLE) is an autoimmune condition with a polymorphic presentation and a complicated, often life-threatening, course. A recent study published in Rheumatology explored the role of caffeine in mitigating endothelial dysfunction in SLE.

About the study

The study included 31 SLE patients (30 female vs 1 male) without other CVD risk factors, including past or current smoking, CVD, chronic renal failure, abnormal blood sugar or cholesterol levels. The median age was 43 years, and the median duration of the disease was 18 months.

SLE autoantigens and serum complement C3 and C4 levels were determined. A food frequency questionnaire was used to determine caffeine intake.

Circulating endothelial progenitor cells (EPC) percentage was determined in the SLE patient samples. In a second set, blood samples from healthy donors who did not consume caffeine were processed in vitro to count the number of EPC colony-forming units (CFUs).

The samples were then assessed post-SLE-serum treatment, with and without caffeine exposure (at two dosages, 0.5 mM and 1 mM). The SLE sera came from non-caffeine users.

Autophagy and apoptosis were analyzed in EPCs co-cultured with coffee, with or without SLE sera added. The scientists also evaluated the A2AR/SIRT3/AMPK pathway and its relationship to EPC impairment.

In SLE patients

The median EPC percentage was 0.03, and the median caffeine intake was 166 mg/day. Coffee was the major source, contributing a median of 160 mg/day. The lowest EPC percentage was in those on glucocorticoid treatment and those with neuropsychiatric lupus. The higher the daily caffeine intake, the higher the EPC percentage.

In the healthy samples treated with SLE sera

The EPCs cultured with SLE sera showed poor morphology and a reduced number of CFUs compared to non-treated EPCs. They also had impaired colony organization. Caffeine exposure restored colony structure improved EPC morphology, and increased the CFU count.

Autophagy effects

SLE serum treatment caused a reduction in the autophagy-associated molecule LC3-II, which returned to normal with caffeine treatment at either dosage.

The levels of p62, a molecule degraded during autophagy, increased with SLE serum treatment but returned to normal with caffeine, indicating reduced autophagy. These changes persisted despite treatment with the lysosomal inhibitors E64d and pepstatin.

The researchers attributed these phenomena to a dysfunction or blockade of autophagy in SLE. Autophagy is vital to cardiovascular health, and its deficiency may underlie endothelial dysfunction in SLE. Previous studies indicate that increased autophagy speeds up EPC maturation, underlining its key role in the growth of new blood vessels.

Apoptosis effects

Annexin V (AV) and Bcl-2 were evaluated for apoptosis. Similar changes were seen with SLE serum treatment, with an initial increase in the percentage of AV-positive cells, which declined with caffeine exposure. Bcl-2 levels decreased with SLE sera exposure and were restored with caffeine treatment.

Signaling effects

Caffeine also restored the SLE sera-induced increase in A2AR levels (which in turn increased the lowered SIRT3 protein levels and AMPK activity to normal levels). The SIRT3-AMPK pathway is crucial in inhibiting endothelial dysfunction by limiting vascular inflammation. Thus, caffeine might exert its positive effects on endothelial health via this pathway.

Conclusion

Caffeine showed a protective effect on endothelial function in SLE patients and healthy donor EPCs treated with SLE sera.

These results corroborate earlier studies showing that caffeine protects against senescence caused by oxidative stress by activating the A2AR/SIRT3/AMPK pathway. In vitro caffeine exposure improved EPC survival and inhibited apoptosis while promoting autophagy through this signaling pathway.

Journal reference:
Dr. Liji Thomas

Written by

Dr. Liji Thomas

Dr. Liji Thomas is an OB-GYN, who graduated from the Government Medical College, University of Calicut, Kerala, in 2001. Liji practiced as a full-time consultant in obstetrics/gynecology in a private hospital for a few years following her graduation. She has counseled hundreds of patients facing issues from pregnancy-related problems and infertility, and has been in charge of over 2,000 deliveries, striving always to achieve a normal delivery rather than operative.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, Liji. (2024, October 09). The new science behind the health benefits of caffeine. News-Medical. Retrieved on November 03, 2024 from https://www.news-medical.net/news/20241009/The-new-science-behind-the-health-benefits-of-caffeine.aspx.

  • MLA

    Thomas, Liji. "The new science behind the health benefits of caffeine". News-Medical. 03 November 2024. <https://www.news-medical.net/news/20241009/The-new-science-behind-the-health-benefits-of-caffeine.aspx>.

  • Chicago

    Thomas, Liji. "The new science behind the health benefits of caffeine". News-Medical. https://www.news-medical.net/news/20241009/The-new-science-behind-the-health-benefits-of-caffeine.aspx. (accessed November 03, 2024).

  • Harvard

    Thomas, Liji. 2024. The new science behind the health benefits of caffeine. News-Medical, viewed 03 November 2024, https://www.news-medical.net/news/20241009/The-new-science-behind-the-health-benefits-of-caffeine.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Matcha green tea enhances cognition and sleep in older adults